Status:
RECRUITING
Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Conditions:
Retinoblastoma
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to find out about the quality of life and health in a group of adults who had retinoblastoma when they were children. By quality of life, we mean how you are feeling about...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patient diagnosed with retinoblastoma at any age
- At least five years from completion of all retinoblastoma-directed therapy
- Able to provide informed consent and/or assent, if indicated
Exclusion
Key Trial Info
Start Date :
March 11 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00639301
Start Date
March 11 2008
End Date
March 1 2026
Last Update
April 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065